Header Logo

Connection

MICHAEL ITTMANN to Piperazines

Back to Details
This is a "connection" page, showing publications MICHAEL ITTMANN has written about Piperazines.
MICHAEL ITTMANN
Connection Strength
0.496
Piperazines
  1. Combination treatment of prostate cancer with FGF receptor and AKT kinase inhibitors. Oncotarget. 2017 Jan 24; 8(4):6179-6192.
    View in: PubMed
    Score: 0.457
  2. AZD4547 targets the FGFR/Akt/SOX2 axis to overcome paclitaxel resistance in head and neck cancer. Cell Oncol (Dordr). 2022 Feb; 45(1):41-56.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.